Health Trials

Central Precocious Puberty

2

Review clinical trials related to Central Precocious Puberty. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty

A Single-Arm, Open-Label, Multicenter, Prospective Clinical Study to Evaluate the Effectiveness and Safety of Leuprorelin 1-Month (4-Week) Formulation Administered for 24 Months in Children with Central Precocious Puberty

Participants needed: 43
Trial details
Phase: Phase 4Age: Up to 10Biological sex: AllType: InterventionalSponsor: LG ChemUpdated: Jul 29, 2026Locations: 1
Eligibility criteria

Tanner stage =>2 [+2]

GnRH-independent precocious puberty, incomplete precocious puberty, progressive... [+7]

Read more
Status: Not yet recruiting

Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

The primary objective of this study is to compare the efficacy of the 3-month formulation and 1-month formulation of triptorelin and to assess the short-term effects of the 3-month formulation of triptorelin on glucose and lipid metabolism, body composition, and bone density in Chinese ICPP patients.

Participants needed: 134
Trial details
Phase: Phase 4Age: 2-10Biological sex: AllType: InterventionalSponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUpdated: Jul 5, 2024Locations: 1
Eligibility criteria

Early appearance of secondary sexual characteristics, specifically breast develo... [+6]

Secondary central precocious puberty: This includes central nervous system abnor... [+6]

Read more